首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release
【24h】

A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release

机译:体外和体内丙烯酸压敏粘合剂贴剂中药物的系统评价:分子间相互作用和粘性迁移率变异在药物控制释放中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Though acrylic pressure sensitive adhesives (PSAs) are widely used in transdermal drug delivery system, molecular details of drug-PSA interactions, PSA molecular mobility variations and their influences on drug skin permeation are unclear. In this study, three classes of acrylic PSAs containing hydroxyl (AAOH), carboxyl (AACOOH) and non-functional group (AAnone) were synthesized. Their abilities of controlling drug release were evaluated using propranolol (PRO) and zaltoprofen (ZAL) in vitro and in vivo. Interaction details were identified by FT-IR, solid-state NMR and molecular modeling. Thermodynamic activity of drug and strength of drug-PSA interaction were characterized using miscibility study. PSA mobility was characterized using thermal analysis and rheology study. Thus, ionic interaction reduced the thermodynamic activity of PRO and mobility of AACOOH, which made PRO-AACOOH obtain a significant lower bioavailability (11.8 +/- 0.7%) than these of PRO-AAnone (40.7 +/- 2.5%) and PRO-AAOH (42.3 +/- 2.9%). Though thermodynamic activity of ZAL in AACOOH was lower than that in AAOH due to the hydrogen bonding, bioavailability of ZAL-AAOH (19.0 +/- 4.1%) exhibited no significant difference with ZAL-AACOOH (15.4 +/- 2.8%), mainly because AAOH mobility was decreased by ZAL. In conclusion, the strength, types and involved functional groups of drug-PSA interactions were identified. On this basis, it was found that different control patterns of drug release were not only caused by the thermodynamic or kinetic hindrance effects of drug-PSA interactions, but also influenced by the interactions introduced PSA mobility variations, which was an innovative mechanism of controlled release in transdermal patch. The conclusions extended our understanding about the mechanism of controlled drug release of drug-in-adhesive patch. In addition, they contributed to the design of TDDS and custom acrylic PSAs. (C) 2017 Elsevier B.V. All rights reserved.
机译:虽然丙烯酸压敏粘合剂(PSAs)广泛用于透皮药物递送系统,但药物-SPS相互作用,PSA分子迁移率变化及其对药物皮肤渗透的影响的分子细节尚不清楚。在该研究中,合成了含有羟基(AaOH),羧基(AACOOH)和非官能团(AANONE)的三类丙烯酸类丙烯酸类碱基PSA。在体外和体内使用ProPranolol(Pro)和ZaltOroprofen(Zal)评估控制药物释放的能力。通过FT-IR,固态NMR和分子模拟鉴定相互作用细节。使用混溶性研究表征药物和药物 - PSA相互作用强度的热力学活性。 PSA移动性的特征是使用热分析和流变学研究表征。因此,离子相互作用降低了AACOOH的PRO和迁移率的PRO和迁移率的热力学活性,所述方法使得较高的生物利用度(11.8 +/- 0.7%)而不是Pro-Aanone(40.7 +/- 2.5%)和Pro- AaOH(42.3 +/- 2.9%)。尽管AACOOH中的Zal的热力学活性低于AaOH,但由于氢键,Zal-AaOH(19.0 +/- 4.1%)的生物利用度与分析 - AacoOH(15.4 +/- 2.8%)没有显着差异因为Zal的AaOH流动性降低。总之,鉴定了药物-SPS相互作用的强度,类型和涉及的官能团。在此基础上,发现药物释放的不同控制模式不仅是由药物-SPS相互作用的热力学或动力学阻碍效应,而且受相互作用的影响引入了PSA迁移率变化,这是一个受控释放的创新机制在透皮贴片中。结论延长了我们对药物粘合剂贴剂的控制药物释放机制的理解。此外,它们有助于TDD和定制丙烯酸类PSA的设计。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号